Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma.

Kuroda T, Ogiwara H, Sasaki M, Takahashi K, Yoshida H, Kiyokawa T, Sudo K, Tamura K, Kato T, Okamoto A, Kohno T
Gynecol Oncol. 2019 Dec;155(3):489-498. doi: 10.1016/j.ygyno.2019.10.002. Epub 2019 Oct 8. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.